This topic contains a solution. Click here to go to the answer

Author Question: In which patient would continued use of an artificial airway be necessary? a. A patient with ... (Read 64 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
In which patient would continued use of an artificial airway be necessary?
 
  a. A patient with upper airway burns and no peritubular leak
  b. A patient who tests positive for a perit-ubular leak
  c. A patient with bronchospasm and supple-mental oxygen requirements
  d. A patient with a strong cough who ex-pectorates moderate amounts of sputum

Question 2

A recently extubated patient develops a partial upper airway obstruction, which causes stridor. What action can the respiratory therapist take to improve the patient's condition?
 
  a. Aerosolize 11.25 mg (2.25 solution) of racemic epinephrine.
  b. Put a nonrebreather mask on the patient.
  c. Place the patient on NPPV.
  d. Suggest the use of lorazepam (Ativan).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

popopong

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

ANS: A
A patient with upper airway burns may have upper airway inflammation that could obstruct the upper airways. The fact that the patient does not have a peritubular leak means that the airway caliber is not adequate. Extubation of this patient at this time would not be successful.

Answer to Question 2

ANS: A
This patient has developed postextubation glottic edema and should be treated immediately with aerosolized racemic epinephrine. The patient also could be given steroids. A nonrebreather mask would not address the upper airway obstruction unless the mask is powered by heliox. This would allow time for the medical treatment to take effect. Use of an antianxiety drug is not in-dicated in this situation, because it would decrease the patient's drive to breathe. Putting the pa-tient on NPPV would not address the patient's immediate problem.




kamilo84

  • Member
  • Posts: 495
Reply 2 on: Jul 16, 2018
YES! Correct, THANKS for helping me on my review


atrochim

  • Member
  • Posts: 331
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Although the Roman numeral for the number 4 has always been taught to have been "IV," according to historians, the ancient Romans probably used "IIII" most of the time. This is partially backed up by the fact that early grandfather clocks displayed IIII for the number 4 instead of IV. Early clockmakers apparently thought that the IIII balanced out the VIII (used for the number 8) on the clock face and that it just looked better.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

For a complete list of videos, visit our video library